Company profile
FENNEC PHARMACEUTICALS INC.
NASDAQ:FENCBiotechnology: Biological Products (No Diagnostic Substances)
Drug pipeline (1)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| Sodium Thiosulfate | approved | — | 0 | — |
Revenue is the latest reported period from SEC filings. A combination product's amount appears on each of its constituent assets, so those rows are not additive.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant | Products | |||
|---|---|---|---|---|---|---|
| NDA 212937 | NDA | FENNEC PHARMACEUTICALS INC | ||||
Loading… | ||||||